Updated:
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001382911, and its reported...
Overview
Orexigen Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001382911, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2017-03-30, it reported annual revenue of USD 33,709,000; net income of USD -24,524,000; total assets of USD 304,589,000 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Orexigen Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- La Jolla, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001382911
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2016USD | $33.7M | -$24.5M | $304.6M | $92.5M | — | |
| FY2015USD | $24.5M | -$68.7M | $236.6M | $155.4M | — | |
| FY2014USD | $55.5M | -$37.5M | $213.0M | $104.2M | — | |
| FY2013USD | $3.4M | -$77.7M | $180.1M | $98.1M | -$70.8M |
FY2015. Total assets: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Orexigen Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.